253 related articles for article (PubMed ID: 26541884)
1. NRF2 Mediates Neuroblastoma Proliferation and Resistance to Retinoic Acid Cytotoxicity in a Model of In Vitro Neuronal Differentiation.
de Miranda Ramos V; Zanotto-Filho A; de Bittencourt Pasquali MA; Klafke K; Gasparotto J; Dunkley P; Gelain DP; Moreira JCF
Mol Neurobiol; 2016 Nov; 53(9):6124-6135. PubMed ID: 26541884
[TBL] [Abstract][Full Text] [Related]
2. Changes in Cell Cycle and Up-Regulation of Neuronal Markers During SH-SY5Y Neurodifferentiation by Retinoic Acid are Mediated by Reactive Species Production and Oxidative Stress.
Kunzler A; Zeidán-Chuliá F; Gasparotto J; Girardi CS; Klafke K; Petiz LL; Bortolin RC; Rostirolla DC; Zanotto-Filho A; de Bittencourt Pasquali MA; Dickson P; Dunkley P; Moreira JCF; Gelain DP
Mol Neurobiol; 2017 Nov; 54(9):6903-6916. PubMed ID: 27771902
[TBL] [Abstract][Full Text] [Related]
3. Gene Expression Profile of NF-κB, Nrf2, Glycolytic, and p53 Pathways During the SH-SY5Y Neuronal Differentiation Mediated by Retinoic Acid.
de Bittencourt Pasquali MA; de Ramos VM; Albanus RDO; Kunzler A; de Souza LHT; Dalmolin RJS; Gelain DP; Ribeiro L; Carro L; Moreira JCF
Mol Neurobiol; 2016 Jan; 53(1):423-435. PubMed ID: 25465239
[TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT and ERK regulate retinoic acid-induced neuroblastoma cellular differentiation.
Qiao J; Paul P; Lee S; Qiao L; Josifi E; Tiao JR; Chung DH
Biochem Biophys Res Commun; 2012 Aug; 424(3):421-6. PubMed ID: 22766505
[TBL] [Abstract][Full Text] [Related]
5. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells.
López-Carballo G; Moreno L; Masiá S; Pérez P; Barettino D
J Biol Chem; 2002 Jul; 277(28):25297-304. PubMed ID: 12000752
[TBL] [Abstract][Full Text] [Related]
6. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
Lee JH; Kim KT
J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
[TBL] [Abstract][Full Text] [Related]
7. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
[TBL] [Abstract][Full Text] [Related]
8. Acrylamide inhibits cellular differentiation of human neuroblastoma and glioblastoma cells.
Chen JH; Chou CC
Food Chem Toxicol; 2015 Aug; 82():27-35. PubMed ID: 25959841
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
Joshi S; Guleria R; Pan J; DiPette D; Singh US
Oncogene; 2006 Jan; 25(2):240-7. PubMed ID: 16158052
[TBL] [Abstract][Full Text] [Related]
10. Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells.
Petit A; Delaune A; Falluel-Morel A; Goullé JP; Vannier JP; Dubus I; Vasse M
Pharmacol Res; 2013 Nov; 77():11-21. PubMed ID: 24004656
[TBL] [Abstract][Full Text] [Related]
11. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid-induced survival effects in SH-SY5Y neuroblastoma cells.
Waetzig V; Haeusgen W; Andres C; Frehse S; Reinecke K; Bruckmueller H; Boehm R; Herdegen T; Cascorbi I
J Cell Biochem; 2019 Apr; 120(4):5974-5986. PubMed ID: 30320919
[TBL] [Abstract][Full Text] [Related]
13. Ouabain-Induced Signaling and Cell Survival in SK-N-SH Neuroblastoma Cells Differentiated by Retinoic Acid.
Akkuratov EE; Wu J; Sowa D; Shah ZA; Liu L
CNS Neurol Disord Drug Targets; 2015; 14(10):1343-9. PubMed ID: 26295826
[TBL] [Abstract][Full Text] [Related]
14. Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol.
Teppola H; Sarkanen JR; Jalonen TO; Linne ML
Neurochem Res; 2016 Apr; 41(4):731-47. PubMed ID: 26518675
[TBL] [Abstract][Full Text] [Related]
15. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
[TBL] [Abstract][Full Text] [Related]
16. Resistance to geldanamycin-induced apoptosis in differentiated neuroblastoma SH-SY5Y cells.
Shen JH; Zhang Y; Wu NH; Shen YF
Neurosci Lett; 2007 Mar; 414(2):110-4. PubMed ID: 17293044
[TBL] [Abstract][Full Text] [Related]
17. Dyngo-4a Induces Neuroblastoma Cell Differentiation Through The AKT and ERK1/2 Pathway.
Huang J; Zhou Y; Zeng S; Xu J; Liu L; Grothusen J; Liu R
CNS Neurol Disord Drug Targets; 2023; 22(10):1526-1534. PubMed ID: 36476431
[TBL] [Abstract][Full Text] [Related]
18. Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells.
Zhu W; Bijur GN; Styles NA; Li X
Brain Res Mol Brain Res; 2004 Jul; 126(1):45-56. PubMed ID: 15207915
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.
Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W
Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
